IL229475A0 - Crystal structure of cyclosporin a, and preparation methods, and methods of using it - Google Patents

Crystal structure of cyclosporin a, and preparation methods, and methods of using it

Info

Publication number
IL229475A0
IL229475A0 IL229475A IL22947513A IL229475A0 IL 229475 A0 IL229475 A0 IL 229475A0 IL 229475 A IL229475 A IL 229475A IL 22947513 A IL22947513 A IL 22947513A IL 229475 A0 IL229475 A0 IL 229475A0
Authority
IL
Israel
Prior art keywords
methods
cyclosporine
preparation
crystalline form
crystalline
Prior art date
Application number
IL229475A
Other languages
English (en)
Hebrew (he)
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46178866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL229475(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IL229475A0 publication Critical patent/IL229475A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/306Extraction; Separation; Purification by precipitation by crystallization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL229475A 2011-05-27 2013-11-17 Crystal structure of cyclosporin a, and preparation methods, and methods of using it IL229475A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161490887P 2011-05-27 2011-05-27
PCT/US2012/039611 WO2012166610A1 (en) 2011-05-27 2012-05-25 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof

Publications (1)

Publication Number Publication Date
IL229475A0 true IL229475A0 (en) 2014-01-30

Family

ID=46178866

Family Applications (2)

Application Number Title Priority Date Filing Date
IL229475A IL229475A0 (en) 2011-05-27 2013-11-17 Crystal structure of cyclosporin a, and preparation methods, and methods of using it
IL290158A IL290158A (en) 2011-05-27 2022-01-27 Crystal structure of cyclosporin a, methods of preparation, and methods of using it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL290158A IL290158A (en) 2011-05-27 2022-01-27 Crystal structure of cyclosporin a, methods of preparation, and methods of using it

Country Status (19)

Country Link
US (4) US8772245B2 (cg-RX-API-DMAC7.html)
EP (2) EP3521302A1 (cg-RX-API-DMAC7.html)
JP (1) JP6163482B2 (cg-RX-API-DMAC7.html)
KR (1) KR102079402B1 (cg-RX-API-DMAC7.html)
CN (1) CN103649108B (cg-RX-API-DMAC7.html)
AR (1) AR086586A1 (cg-RX-API-DMAC7.html)
AU (4) AU2012262513B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013030554B1 (cg-RX-API-DMAC7.html)
CA (1) CA2836946C (cg-RX-API-DMAC7.html)
CL (1) CL2013003400A1 (cg-RX-API-DMAC7.html)
IL (2) IL229475A0 (cg-RX-API-DMAC7.html)
MX (1) MX362271B (cg-RX-API-DMAC7.html)
MY (1) MY180581A (cg-RX-API-DMAC7.html)
RU (1) RU2602062C2 (cg-RX-API-DMAC7.html)
SG (1) SG10201607344UA (cg-RX-API-DMAC7.html)
TW (1) TWI554522B (cg-RX-API-DMAC7.html)
UA (1) UA113627C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012166610A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201308665B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2779994T3 (da) * 2011-11-15 2020-05-18 Allergan Inc Suspensioner af cyclosporin a form 2
AU2012339695B2 (en) * 2011-11-15 2017-10-05 Allergan, Inc. Sustained action formulation of cyclosporin Form 2
RU2635547C2 (ru) 2011-11-15 2017-11-14 Аллерган, Инк. Форма 2 циклоспорина а и способ ее получения
WO2013074616A1 (en) * 2011-11-15 2013-05-23 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
CN104487449A (zh) 2012-06-01 2015-04-01 阿勒根公司 环孢菌素a类似物
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
US10524661B2 (en) * 2013-06-12 2020-01-07 Proactive Live, Inc. Sleep monitoring and stimulation
AU2015289387B2 (en) 2014-07-18 2020-10-22 Allergan, Inc. Suspension compositions of cyclosporin A for subconjunctival and periocular injection
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
US10443292B2 (en) * 2016-04-25 2019-10-15 Magna Closures, Inc. Non-contact obstacle detection system for motor vehicles
RU2766160C2 (ru) 2017-05-17 2022-02-08 Юю Фарма, Инк. Новый пептид и фармацевтический состав для лечения глазного заболевания, содержащий пептид в качестве активного фармацевтического ингредиента
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
KR20250088544A (ko) 2022-10-20 2025-06-17 추가이 세이야쿠 가부시키가이샤 고리형 펩티드 결정을 제조하는 방법
JPWO2024195801A1 (cg-RX-API-DMAC7.html) 2023-03-20 2024-09-26

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
US6254860B1 (en) 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
CN101687013A (zh) * 2007-05-04 2010-03-31 阿勒根公司 环孢菌素在治疗具有人工晶状体的患者中的用途
BRPI0822221A2 (pt) * 2008-01-04 2015-06-23 Alcon Pharmaceuticals Ltd Composições aquosas e estáveis de ciclosporina

Also Published As

Publication number Publication date
US20140315827A1 (en) 2014-10-23
JP2014515372A (ja) 2014-06-30
RU2602062C2 (ru) 2016-11-10
CL2013003400A1 (es) 2014-08-18
CN103649108B (zh) 2017-03-29
US8772245B2 (en) 2014-07-08
SG10201607344UA (en) 2016-10-28
MY180581A (en) 2020-12-02
BR112013030554A2 (pt) 2016-09-06
KR20140047054A (ko) 2014-04-21
AR086586A1 (es) 2014-01-08
KR102079402B1 (ko) 2020-02-19
WO2012166610A1 (en) 2012-12-06
IL290158A (en) 2022-03-01
EP2714720A1 (en) 2014-04-09
US20210269484A1 (en) 2021-09-02
NZ719272A (en) 2017-10-27
EP2714720B1 (en) 2018-12-26
UA113627C2 (xx) 2017-02-27
NZ618213A (en) 2016-05-27
AU2012262513B2 (en) 2016-03-17
AU2012262513A1 (en) 2013-12-12
TWI554522B (zh) 2016-10-21
CA2836946C (en) 2017-08-01
TW201311730A (zh) 2013-03-16
CN103649108A (zh) 2014-03-19
AU2019204192A1 (en) 2019-07-04
MX2013013855A (es) 2014-02-17
BR112013030554B1 (pt) 2020-12-15
AU2019204192B2 (en) 2021-02-04
US20160083432A1 (en) 2016-03-24
MX362271B (es) 2019-01-10
EP3521302A1 (en) 2019-08-07
CA2836946A1 (en) 2012-12-06
ZA201308665B (en) 2014-07-30
US9206228B2 (en) 2015-12-08
US20130023482A1 (en) 2013-01-24
AU2017265008A1 (en) 2017-12-07
RU2013155033A (ru) 2015-07-20
JP6163482B2 (ja) 2017-07-12
AU2016203990A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
IL290158A (en) Crystal structure of cyclosporin a, methods of preparation, and methods of using it
HUE037674T2 (hu) Eljárás uliprisztál-acetát és intermedierjének elõállítására
ZA201306316B (en) Methods and compositions for preparing noribogaine from voacangine
ZA201305972B (en) Method for the preparation of biphephos
GB201110042D0 (en) Growth of cells
SG10201604667YA (en) Pharmaceutical preparation
ZA201403858B (en) Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof
PL2785701T3 (pl) Krystaliczna postać kabazytakselu i sposób jej otrzymywania
IL225972A0 (en) Salts of cocuamine b, a method for their preparation and use
EP2731429A4 (en) COMPOUNDS, METHODS OF PREPARATION AND METHODS OF USE
EP2763998A4 (en) TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
PL3210991T3 (pl) Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie
EP2766375A4 (en) PREPARATION OF NEW FLUORIN COMPOUNDS, METHOD OF MANUFACTURING AND COMPOSITIONS MADE THEREOF
GB201105298D0 (en) Pharmaceutical preparation
ZA201305277B (en) Phenyl-isoxazol derivatives and preparation process thereof
EP2698159A4 (en) PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF
IL226436A0 (en) Methods for the preparation of bendamustine
GB2492213B (en) Prosthesis
EP2769975A4 (en) INTERMEDIATE OF BENZOXAZINE AND PROCESS FOR PREPARING THE SAME
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
PL2691119T3 (pl) Preparat farmaceutyczny
IL230977A (en) A crystalline form of relapaldib
PT2655363T (pt) Formas cristalinas e processos para a sua preparação
SG11201405376TA (en) CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF
IL226329A (en) Method for preparing methaxalone